{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:11:22Z","timestamp":1794892282705,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K99AR081897"],"award-info":[{"award-number":["K99AR081897"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R00AR081897"],"award-info":[{"award-number":["R00AR081897"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR066261"],"award-info":[{"award-number":["P30AR066261"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR075042"],"award-info":[{"award-number":["P30AR075042"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P01DK011794"],"award-info":[{"award-number":["P01DK011794"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK116716"],"award-info":[{"award-number":["R01DK116716"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Osteogenesis imperfecta (OI) is a group of diseases caused by defects in type I collagen processing which result in skeletal fragility. While these disorders have been regarded as defects in osteoblast function, the role of matrix-embedded osteocytes in OI pathogenesis remains largely unknown. Homozygous human <jats:italic>SP7<\/jats:italic> (<jats:italic>c.946<\/jats:italic>\u2009<jats:italic>C<\/jats:italic>\u2009&gt;\u2009<jats:italic>T<\/jats:italic>, <jats:italic>R316C<\/jats:italic>) mutation results in a recessive form of OI characterized by fragility fractures, low bone mineral density and osteocyte dendrite defects. To better understand how the OI-causing <jats:italic>R316C<\/jats:italic> mutation affects the function of SP7, we generated <jats:italic>Sp7<\/jats:italic>\n            <jats:sup>\n              <jats:italic>R342C<\/jats:italic>\n            <\/jats:sup> knock-in mice. Consistent with patient phenotypes, <jats:italic>Sp7<\/jats:italic>\n            <jats:sup>\n              <jats:italic>R342C\/R342C<\/jats:italic>\n            <\/jats:sup> mice demonstrate increased cortical porosity and reduced cortical bone mineral density. <jats:italic>Sp7<\/jats:italic>\n            <jats:sup>\n              <jats:italic>R342C\/R342C<\/jats:italic>\n            <\/jats:sup> mice show osteocyte dendrite defects, increased osteocyte apoptosis, and intracortical bone remodeling with ectopic intracortical osteoclasts and elevated osteocyte <jats:italic>Tnfsf11<\/jats:italic> expression. Remarkably, these defects in osteocyte function contrast to only mild changes in mature osteoblast function, suggesting that this <jats:italic>Sp7<\/jats:italic> mutation selectively interferes with the function of Sp7 in osteocytes and mature osteoblasts, but not during early stages of osteoblast differentiation. Osteocyte morphology changes in <jats:italic>Sp7<\/jats:italic>\n            <jats:sup>\n              <jats:italic>R342C\/R342C<\/jats:italic>\n            <\/jats:sup> mice were not restored by inhibiting osteoclast formation, indicating that dendrite defects lie upstream of high intracortical osteoclast activity in this model. Moreover, transcriptomic profiling reveals that the expression of a core set osteocyte-enriched genes is highly dysregulated by the <jats:italic>R342C<\/jats:italic> mutation. Thus, this supports a model in which osteocyte dysfunction can drive OI pathogenesis and provides a valuable resource to test novel therapeutic approaches and to understand the osteocyte-specific role of SP7 in bone remodeling.<\/jats:p>","DOI":"10.1038\/s41413-025-00440-1","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T08:40:33Z","timestamp":1752914433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Osteoclast-independent osteocyte dendrite defects in mice bearing the osteogenesis imperfecta-causing Sp7 R342C mutation"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-7619","authenticated-orcid":false,"given":"Jialiang S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Numa","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Bouxsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristal S.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-2897","authenticated-orcid":false,"given":"Tamara N.","family":"Alliston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-8147","authenticated-orcid":false,"given":"Marc N.","family":"Wein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"440_CR1","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino, A. & Marini, J. C. Osteogenesis imperfecta. Lancet 387, 1657\u20131671 (2016).","journal-title":"Lancet"},{"key":"440_CR2","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini, J. C. et al. Osteogenesis imperfecta. Nat. Rev. Dis. Prim. 3, 17052 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"440_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/endrev\/bnab017","volume":"43","author":"M Jovanovic","year":"2021","unstructured":"Jovanovic, M., Guterman-Ram, G. & Marini, J. C. Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types. Endocr. Rev. 43, 61\u201390 (2021).","journal-title":"Endocr. Rev."},{"key":"440_CR4","doi-asserted-by":"crossref","unstructured":"Wang, J. S. & Wein, M. N. Pathways controlling formation and maintenance of the osteocyte dendrite network. Curr. Osteoporos. Rep. 1\u201312 493\u2013504 (2022).","DOI":"10.1007\/s11914-022-00753-8"},{"key":"440_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH704>3.0.CO;2-U","volume":"192","author":"P Sarathchandra","year":"2000","unstructured":"Sarathchandra, P., Pope, F. M., Kayser, M. V. & Ali, S. Y. A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype. J. Pathol. 192, 385\u2013395 (2000).","journal-title":"J. Pathol."},{"key":"440_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nm.3544","volume":"20","author":"I Grafe","year":"2014","unstructured":"Grafe, I. et al. Excessive transforming growth factor-\u03b2 signaling is a common mechanism in osteogenesis imperfecta. Nat. Med. 20, 670\u2013675 (2014).","journal-title":"Nat. Med."},{"key":"440_CR7","doi-asserted-by":"publisher","first-page":"17010","DOI":"10.3390\/ijms242317010","volume":"24","author":"G Andr\u00e9","year":"2023","unstructured":"Andr\u00e9, G. et al. Col1A-2 mutation in osteogenesis imperfecta mice contributes to long bone fragility by modifying cell-matrix organization. Int. J. Mol. Sci. 24, 17010 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"440_CR8","doi-asserted-by":"publisher","first-page":"116927","DOI":"10.1016\/j.bone.2023.116927","volume":"177","author":"T Danyukova","year":"2023","unstructured":"Danyukova, T. et al. Mice heterozygous for an osteogenesis imperfecta-linked MBTPS2 variant display a compromised subchondral osteocyte lacunocanalicular network associated with abnormal articular cartilage. Bone 177, 116927 (2023).","journal-title":"Bone"},{"key":"440_CR9","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.3390\/ijms22094508","volume":"22","author":"M M\u00e4hr","year":"2021","unstructured":"M\u00e4hr, M. et al. Increased osteocyte lacunae density in the hypermineralized bone matrix of children with osteogenesis imperfecta type I. Int. J. Mol. Sci. 22, 4508 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"440_CR10","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/jbmr.3180","volume":"32","author":"S Blouin","year":"2017","unstructured":"Blouin, S. et al. Hypermineralization and high osteocyte lacunar density in osteogenesis imperfecta type V bone indicate exuberant primary bone formation. J. Bone Miner. Res. 32, 1884\u20131892 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"440_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","volume":"108","author":"K Nakashima","year":"2002","unstructured":"Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17\u201329 (2002).","journal-title":"Cell"},{"key":"440_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41413-019-0064-9","volume":"7","author":"W Xing","year":"2019","unstructured":"Xing, W., Godwin, C., Pourteymoor, S. & Mohan, S. Conditional disruption of the osterix gene in chondrocytes during early postnatal growth impairs secondary ossification in the mouse tibial epiphysis. Bone Res. 7, 24 (2019).","journal-title":"Bone Res."},{"key":"440_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26571-7","volume":"12","author":"JS Wang","year":"2021","unstructured":"Wang, J. S. et al. Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin. Nat. Commun. 12, 6271 (2021).","journal-title":"Nat. Commun."},{"key":"440_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1177\/154405910708600404","volume":"86","author":"Y Lu","year":"2007","unstructured":"Lu, Y. et al. DMP1-targeted Cre expression in odontoblasts and osteocytes. J. Dent. Res. 86, 320\u2013325 (2007).","journal-title":"J. Dent. Res."},{"key":"440_CR15","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.3390\/ijms23063173","volume":"23","author":"T Moriishi","year":"2022","unstructured":"Moriishi, T. et al. Sp7 transgenic mice with a markedly impaired lacunocanalicular network induced sost and reduced bone mass by unloading. Int. J. Mol. Sci. 23, 3173 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"440_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bone.2018.01.031","volume":"110","author":"M Fiscaletti","year":"2018","unstructured":"Fiscaletti, M. et al. Novel variant in Sp7\/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment. Bone 110, 66\u201375 (2018).","journal-title":"Bone"},{"key":"440_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajhg.2010.05.016","volume":"87","author":"P Lapunzina","year":"2010","unstructured":"Lapunzina, P. et al. Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am. J. Hum. Genet. 87, 110\u2013114 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"440_CR18","doi-asserted-by":"publisher","first-page":"116400","DOI":"10.1016\/j.bone.2022.116400","volume":"160","author":"K Ludwig","year":"2022","unstructured":"Ludwig, K. et al. Dominant osteogenesis imperfecta with low bone turnover caused by a heterozygous SP7 variant. Bone 160, 116400 (2022).","journal-title":"Bone"},{"key":"440_CR19","doi-asserted-by":"crossref","unstructured":"Wang, J. S., Tokavanich, N. & Wein, M. N. SP7: from bone development to skeletal disease. Curr. Osteoporos. Rep. 21, 241\u2013252 (2023).","DOI":"10.1007\/s11914-023-00778-7"},{"key":"440_CR20","volume":"8","author":"DA Al-Mutairi","year":"2024","unstructured":"Al-Mutairi, D. A. et al. A homozygous SP7\/OSX mutation causes osteogenesis and dentinogenesis imperfecta with craniofacial anomalies. JBMR 8, ziae026 (2024).","journal-title":"JBMR"},{"key":"440_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1400-x","volume":"19","author":"M Ohtsuka","year":"2018","unstructured":"Ohtsuka, M. et al. i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases. Genome Biol. 19, 25 (2018).","journal-title":"Genome Biol."},{"key":"440_CR22","doi-asserted-by":"publisher","first-page":"100148","DOI":"10.1016\/j.xhgg.2022.100148","volume":"4","author":"C Young","year":"2023","unstructured":"Young, C. et al. A hypomorphic variant in the translocase of the outer mitochondrial membrane complex subunit TOMM7 causes short stature and developmental delay. Hum. Genet. Genom. Adv. 4, 100148 (2023).","journal-title":"Hum. Genet. Genom. Adv."},{"key":"440_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22517-1","volume":"12","author":"SE Youlten","year":"2021","unstructured":"Youlten, S. E. et al. Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease. Nat. Commun. 12, 2444 (2021).","journal-title":"Nat. Commun."},{"key":"440_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/gtc.12593","volume":"23","author":"S Mii","year":"2018","unstructured":"Mii, S. et al. CD109 deficiency induces osteopenia with an osteoporosis\u2010like phenotype in vivo. Genes Cells 23, 590\u2013598 (2018).","journal-title":"Genes Cells"},{"key":"440_CR25","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41588-023-01444-5","volume":"55","author":"S Zhou","year":"2023","unstructured":"Zhou, S. et al. Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis. Nat. Genet. 55, 1277\u20131287 (2023).","journal-title":"Nat. Genet."},{"key":"440_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138815","volume":"5","author":"H-N Kim","year":"2020","unstructured":"Kim, H.-N. et al. Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence. JCI Insight 5, e138815 (2020).","journal-title":"JCI Insight"},{"key":"440_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41413-023-00303-7","volume":"12","author":"CA Schurman","year":"2024","unstructured":"Schurman, C. A. et al. Aging impairs the osteocytic regulation of collagen integrity and bone quality. Bone Res. 12, 13 (2024).","journal-title":"Bone Res."},{"key":"440_CR28","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2165","volume":"9","author":"BF Boyce","year":"2007","unstructured":"Boyce, B. F. & Xing, L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 9, S1 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"440_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce, B. F. & Xing, L. Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473, 139\u2013146 (2008).","journal-title":"Arch. Biochem. Biophys."},{"key":"440_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet, W. S. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309\u2013319 (1997).","journal-title":"Cell"},{"key":"440_CR31","doi-asserted-by":"crossref","unstructured":"Yoon, S.-H. et al. A parathyroid hormone\/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. J. Clin. Investig. 133, e163627 (2023).","DOI":"10.1172\/JCI163627"},{"key":"440_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bone.2017.02.004","volume":"102","author":"J Lim","year":"2017","unstructured":"Lim, J., Grafe, I., Alexander, S. & Lee, B. Genetic causes and mechanisms of Osteogenesis Imperfecta. Bone 102, 40\u201349 (2017).","journal-title":"Bone"},{"key":"440_CR33","doi-asserted-by":"crossref","unstructured":"Marom, R. et al. The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK\/SOX9-dependent osteoprogenitor differentiation defect. J. Clin. Investig. 134, e170369 (2024).","DOI":"10.1172\/JCI170369"},{"key":"440_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bone.2013.12.020","volume":"61","author":"A Carriero","year":"2014","unstructured":"Carriero, A. et al. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility. Bone 61, 116\u2013124 (2014).","journal-title":"Bone"},{"key":"440_CR35","doi-asserted-by":"publisher","first-page":"115364","DOI":"10.1016\/j.bone.2020.115364","volume":"137","author":"MP Whyte","year":"2020","unstructured":"Whyte, M. P. et al. Juvenile Paget\u2019s disease from heterozygous mutation of SP7 encoding osterix (Specificity Protein 7, Transcription Factor SP7). Bone 137, 115364 (2020).","journal-title":"Bone"},{"key":"440_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28318-4","volume":"13","author":"JC Lui","year":"2022","unstructured":"Lui, J. C. et al. A neomorphic variant in SP7 alters sequence specificity and causes a high-turnover bone disorder. Nat. Commun. 13, 700 (2022).","journal-title":"Nat. Commun."},{"key":"440_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1172\/JCI71101","volume":"124","author":"ES Orwoll","year":"2014","unstructured":"Orwoll, E. S. et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J. Clin. Investig. 124, 491\u2013498 (2014).","journal-title":"J. Clin. Investig."},{"key":"440_CR38","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/jbmr.3143","volume":"32","author":"FH Glorieux","year":"2017","unstructured":"Glorieux, F. H. et al. BPS804 anti\u2010sclerostin antibody in adults with moderate osteogenesis imperfecta: results of a randomized phase 2a Trial. J. Bone Miner. Res. 32, 1496\u20131504 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"440_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152571","volume":"132","author":"I-W Song","year":"2022","unstructured":"Song, I.-W. et al. Targeting transforming growth factor- \u03b2 (TGF-\u03b2) for treatment of osteogenesis imperfecta. J. Clin. Investig. 132, e152571 (2022).","journal-title":"J. Clin. Investig."},{"key":"440_CR40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jbmr.2539","volume":"30","author":"KJ Jepsen","year":"2015","unstructured":"Jepsen, K. J., Silva, M. J., Vashishth, D., Guo, X. E. & Meulen, M. C. van der. establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones. J. Bone Miner. Res. 30, 951\u2013966 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"440_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2\u201317 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"440_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-1-0716-1028-2_17","volume":"2230","author":"NS Dole","year":"2020","unstructured":"Dole, N. S., Yee, C. S., Schurman, C. A., Dallas, S. L. & Alliston, T. Skeletal development and repair, methods and protocols. Methods Mol. Biol. 2230, 303\u2013323 (2020).","journal-title":"Methods Mol. Biol."},{"key":"440_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bone.2015.02.011","volume":"76","author":"SA Kamel-ElSayed","year":"2015","unstructured":"Kamel-ElSayed, S. A., Tiede-Lewis, L. M., Lu, Y., Veno, P. A. & Dallas, S. L. Novel approaches for two and three dimensional multiplexed imaging of osteocytes. Bone 76, 129\u2013140 (2015).","journal-title":"Bone"},{"key":"440_CR44","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.18632\/aging.101308","volume":"9","author":"LM Tiede-Lewis","year":"2017","unstructured":"Tiede-Lewis, L. M. et al. Degeneration of the osteocyte network in the C57BL\/6 mouse model of aging. Aging Albany 9, 2190\u20132208 (2017).","journal-title":"Aging Albany"},{"key":"440_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023999118","volume":"118","author":"CA Schurman","year":"2021","unstructured":"Schurman, C. A., Verbruggen, S. W. & Alliston, T. Disrupted osteocyte connectivity and pericellular fluid flow in bone with aging and defective TGF-\u03b2 signaling. Proc. Natl. Acad. Sci. USA 118, e2023999118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"440_CR46","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"440_CR47","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.bone.2010.08.023","volume":"47","author":"M Doube","year":"2010","unstructured":"Doube, M. et al. BoneJ: free and extensible bone image analysis in ImageJ. Bone 47, 1076\u20131079 (2010).","journal-title":"Bone"},{"key":"440_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"440_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"440_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128 (2013).","journal-title":"BMC Bioinform."},{"key":"440_CR51","doi-asserted-by":"publisher","unstructured":"Maridas, D. E., Rendina-Ruedy, E., Le, P. T. & Rosen, C. J. Isolation, culture, and differentiation of bone marrow stromal cells and osteoclast progenitors from mice. J. Vis. Exp. https:\/\/doi.org\/10.3791\/56750 (2018).","DOI":"10.3791\/56750"}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00440-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00440-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00440-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:44:59Z","timestamp":1757259899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00440-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1038\/s41413-025-00440-1","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare competing interest. M.N.W. has received research funding from Radius Health and is a co-inventor on pending patents regarding the use of SIK inhibitors for osteoporosis. M.N.W. serves as a consultant for Relation Therapeutics, Sitryx Therapeutics, Aditum Bio, and GLG.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}